David Bredt - Chief Scientific Officer at Rapport Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
RAPP on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Bredt since 11/5/2023

Holdings reported by David Bredt for Rapport Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 478K Jun 6, 2024 Direct
Stock Option (Right to Buy) 28.3K Jun 6, 2024 Direct Common Stock

Transactions reported by David Bredt for Rapport Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.